Back to Search Start Over

Role of ERK1/2 activation and nNOS uncoupling on endothelial dysfunction induced by lysophosphatidylcholine.

Authors :
Campos-Mota GP
Navia-Pelaez JM
Araujo-Souza JC
Stergiopulos N
Capettini LSA
Source :
Atherosclerosis [Atherosclerosis] 2017 Mar; Vol. 258, pp. 108-118. Date of Electronic Publication: 2016 Nov 18.
Publication Year :
2017

Abstract

Background and Aims: Lysophosphatidylcholine (LPC) - a main component of oxidized LDL - is involved in endothelial dysfunction that precedes atherosclerosis, with an increased superoxide anions and a reduced NO production via endothelial NO synthase (eNOS) uncoupling. However, there is no evidence about the mechanisms involved in neuronal NOS (nNOS) uncoupling. Extracellular signal-regulated kinase (ERK) is related to the control of NO production and inflammatory gene transcription activation in atherosclerosis. Our aim was to investigate the role of nNOS/ERK1/2 pathway on endothelial dysfunction induced by LPC, in mouse aorta and human endothelial cells.<br />Methods: Thoracic aorta from wild type mice was used to perform vascular reactivity studies in the presence or absence of LPC. Human endothelial cells were used to investigate the effect of LPC on expression of nNOS and his products NO and H <subscript>2</subscript> O <subscript>2</subscript> .<br />Results: LPC reduced acetylcholine (ACh)-induced vasodilation in mouse aorta (Emax <subscript>CT/LPC</subscript>  = ∼95 ± 2/62 ± 3%, p = 0.0004) and increased phenylephrine-induced vasoconstriction (Emax <subscript>CT/LPC</subscript>  = ∼4 ± 0,1/6 ± 0,1 mN/mm, p = 0.0002), with a reduction in NO (fluorescence intensity <subscript>CT/LPC</subscript>  = 91 ± 3/62±2 × 10 <superscript>3</superscript> , p = 0.0002) and H <subscript>2</subscript> O <subscript>2</subscript> (fluorescence intensity <subscript>CT/LPC</subscript>  = ∼16 ± 0,8/10 ± 0,7 × 10 <superscript>3</superscript> , p = 0.0041) production evocated by ACh. An inhibition of nNOS by TRIM (Emax <subscript>CT/CT+TRIM</subscript>  = ∼93 ± 1/43 ± 3%, p = 0,0048; Emax <subscript>LPC/LPC+TRIM</subscript>  = ∼62 ± 3/65 ± 3%) or H <subscript>2</subscript> O <subscript>2</subscript> degradation by catalase (Emax <subscript>CT/CT+cat</subscript>  = ∼93 ± 1/46 ± 2%, p < 0,001; Emax <subscript>LPC/LPC+cat</subscript>  = ∼62,8 ± 3,2/60,5 ± 4,7%) reduced the relaxation in the control but not in LPC group. PD98059, an ERK1/2 inhibitor, abolished the increase in vasoconstriction in LPC-treated vessels (Emax <subscript>LPC/LPC+PD</subscript>  = ∼6 ± 0,1/3 ± 0,1 mN/mm, p = 0.0001). LPC also reduced the dimer/monomer proportion and increased nNOS <superscript>ser852</superscript> phosphorylation.<br />Conclusions: LPC induced nNOS uncoupling and nNOS <superscript>Ser852</superscript> phosphorylation, reduced NO and H <subscript>2</subscript> O <subscript>2</subscript> production and improved superoxide production by modulating ERK1/2 activity in human and murine endothelial cells.<br /> (Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1879-1484
Volume :
258
Database :
MEDLINE
Journal :
Atherosclerosis
Publication Type :
Academic Journal
Accession number :
28235709
Full Text :
https://doi.org/10.1016/j.atherosclerosis.2016.11.022